Hoplite Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-359,850
Closed -$62.2M 41
2015
Q1
$62.2M Sell
359,850
-214,528
-37% -$31.5M 1.92% 24
2014
Q4
$66M Hold
574,378
1.83% 27
2014
Q3
$89.7M Buy
+574,378
New +$83.3M 2.29% 23

Other funds holding SLXP

Hoplite Capital Management's SLXP Position: Q2 2015 in Review

Hoplite Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 359,850 shares — an estimated $62.2M sold.

Hoplite Capital Management first reported a position in SLXP in Q3 2014 and held it in 3 quarters. The position peaked at $89.7M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Hoplite Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Hoplite Capital Management sold 359,850 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $62.2M.
  • Hoplite Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 3 quarters.
  • Hoplite Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $89.7M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Hoplite Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.